In Parkinson’s disease, the protein alpha-synuclein changes shape, and we think it transfers around the brain. We want to see if we can recreate this in non-human primates.
We are testing the hypothesis that we can get alpha-synuclein to transfer from site to site around the primate brain.
Eight models will be part of this study. Four will receive alpha-synuclein and four will receive placebo. After six months we will examine the model brain and analyze protein transference.
Impact on Diagnosis/Treatment of Parkinson’s Disease:
This understanding will provide a model for which therapeutic strategies based upon the transfer of this modified protein can be tested.
Next Steps for Development:
We will use this model to test novel therapies aimed at preventing the transfer of alpha-synuclein around the brain.